These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 5337669)
1. Immunity to the 6C3HED ascites tumor following treatment of tumor-bearing mice with Escherichia coli L-asparaginase. Prager MD; Roberts J; Bachynsky N J Immunol; 1967 May; 98(5):1045-52. PubMed ID: 5337669 [No Abstract] [Full Text] [Related]
3. Inhibition of lymphoma 6C3HED by L-asparaginase from Serratia marcescens. Boyd JW; Phillips AW J Natl Cancer Inst; 1971 Jun; 46(6):1271-6. PubMed ID: 4932428 [No Abstract] [Full Text] [Related]
4. The antitumor activity of Escherichia coli L-asparaginase. Roberts J; Prager MD; Bachynsky N Cancer Res; 1966 Oct; 26(10):2213-7. PubMed ID: 5331901 [No Abstract] [Full Text] [Related]
5. The effects of immunization to L-asparaginase on antitumor and enzymatic activity. Goldberg AI; Cooney DA; Glynn JP; Homan ER; Gaston MR; Milman HA Cancer Res; 1973 Feb; 33(2):256-61. PubMed ID: 4569788 [No Abstract] [Full Text] [Related]
6. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli. Charles LM; Bono VH Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380 [No Abstract] [Full Text] [Related]
7. Enhancement of asparaginase-induced regression of the 6C3HED lymphosarcoma by protein-free diet. Ryan WL; Sornson HC Cancer Res; 1973 May; 33(5):1062-4. PubMed ID: 4574058 [No Abstract] [Full Text] [Related]
8. Amino acids of the 6C3HED lymphosarcoma following treatment with asparaginase. Ryan WL; Dworak JE Cancer Res; 1970 Apr; 30(4):1206-9. PubMed ID: 4926800 [No Abstract] [Full Text] [Related]
9. Inhibition of thymidine and basic amino acid metabolism in P1798 lymphosarcoma by L-asparaginase. Mashburn LT; Landin LM Cancer Res; 1974 Feb; 34(2):313-8. PubMed ID: 4589953 [No Abstract] [Full Text] [Related]
10. The effect of splenectomy on tumor immunity and the metastatic spread of a murine reticulum cell sarcoma. Faraci RP; Marrone JC; Lesser GR; Ketcham AS Panminerva Med; 1975 Mar; 17(3):59-64. PubMed ID: 1096028 [No Abstract] [Full Text] [Related]
11. Principal biochemical characteristics of the EC-2 L-asparaginase from Escherichia coli AT. Smékal F Neoplasma; 1969; 16(4):469-70. PubMed ID: 4899032 [No Abstract] [Full Text] [Related]
12. LDH-viral activity transferred with cell surface antigens of Gardner lymphosarcoma cells. Short communication. Motycka K; Bostík J; Slavík K; Bures L; Pezlarová J; Jandová A Z Versuchstierkd; 1984; 26(5):209-10. PubMed ID: 6549095 [No Abstract] [Full Text] [Related]
13. Effect of heterologous antilymphoid-cell serum on tumor isografts and viral leukemogenesis. Bremberg S; Klein E; Stjernswärd J Cancer Res; 1967 Nov; 27(11):2113-8. PubMed ID: 4294531 [No Abstract] [Full Text] [Related]
14. Advantages in the use of L-asparaginase-albumin polymer as an antitumor agent. Poznansky MJ; Shandling M; Salkie MA; Elliott JF; Lau E Cancer Res; 1982 Mar; 42(3):1020-5. PubMed ID: 6895861 [TBL] [Abstract][Full Text] [Related]
16. The effect of L-asparaginase on the antibody response of tumor-bearing mice. Hutto J; Hamlin NM; Hiramoto R Ala J Med Sci; 1970 Jan; 7(1):61-4. PubMed ID: 5468125 [No Abstract] [Full Text] [Related]
17. The effect of storage at low temperatures on the mouse strain specificity of the 6C3HED ascites tumor. Morgan JF; Heuchert MD; Kirk HD Cancer Res; 1969 Apr; 29(4):855-61. PubMed ID: 5818519 [No Abstract] [Full Text] [Related]
18. L-Asparaginase: discovery and development as a tumor-inhibitory agent. Broome JD Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374 [No Abstract] [Full Text] [Related]
19. 51 Cr-L-asparagine accumulation by tumors: the influence of L-asparaginase treatment. Anghileri LJ J Nucl Biol Med; 1970; 14(4):150-2. PubMed ID: 5538035 [No Abstract] [Full Text] [Related]
20. [Bacterial L-asparaginase and glutamin(asparagin)ase: some properties, structure and anti-tumor activity]. Sokolov NN; Zanin VA; Aleksandrova SS Vopr Med Khim; 2000; 46(6):531-48. PubMed ID: 11234278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]